RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, announced today the closing of its initial public offering of 238,050,000 shares of its common stock at a price to the public of $14.00per share, […]

BEVERLY, Mass. — Sage Science, a developer of products for improving sample preparation processes in life science applications, today announced the award of $1.8M from the National Human Genome Research Institute. The grant funds a two-year program to develop and commercialize a fully automated platform for its HLS-CATCH targeted DNA sample preparation process. The HLS-CATCH […]

New funding to support platform advancements and proprietary pipeline expansion NEW YORK – Schrödinger today announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry-leading computational platform and expansion of its therapeutic pipeline. New investors include […]

– Avantor enterprise value grows from $280 million in 2010 to over $14 billion today, under New Mountain’s ownership – Avantor has emerged as a global leader in life sciences materials NEW YORK–New Mountain Capital, LLC, (“New Mountain”), a growth-oriented private equity firm with over $20 billion in assets under management, today announced the initial […]

Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S. PARIS – DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most experienced healthcare investment firms. Bpifrance, through its Large Venture fund, joined the round, alongside existing investors Illumina Ventures, […]

BRANFORD, Conn. — IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had raised $25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations. In […]

PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, today announced it has closed a $50 million debt facility from Silicon Valley Bank (SVB) to further support its working capital growth, along with adding dry powder for future acquisitions. The agreement allows the company to retire its […]

On May 9, 2019, MGI disclosed that its first round of fundraising exceeded US$200 million, the largest amount of capital raised in the genetic field in China in 2018. Investors included well-known institutions such as CITIC, Jinshi Capital, Songhe Capital and Dongzheng Capital. MGI Highlights Rapid Progress in Transforming Industry In recent years, the gene […]

Genome Diagnostics B.V. (“GenDx”) announced today that Ampersand Capital Partners has completed a minority, growth equity investment in the company. Wietse Mulder, PhD., remains the majority shareholder and CEO of GenDx. The partnership between Ampersand and GenDx aims to foster sustainable growth, both organically and through M&A activities in the molecular diagnostic products and services […]

FUNDS WILL ENABLE DEVELOPMENT OF INSTRUMENT TO RAPIDLY AND DIRECTLY ANALYZE DRINKING WATER SAMPLES AT THE POINT OF COLLECTION.   FAYETTEVILLE, AR – Zebra Analytix™, a VIC Technology Venture Development portfolio company, announced today that it has received a National Institute of Environment Health Sciences (NIEHS) Small Business Innovation Research (SBIR) grant in the amount of $225,000. […]